Table of Content

Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing the Study
Intended Audience
Scope and Format
Methodology
Information Sources
Geographical Breakdown
Analyst’s Credentials

Chapter 2 Summary and Highlights

Chapter 3 Overview
Introduction to Artificial Intelligence
Understanding Artificial Intelligence in Healthcare
Artificial Intelligence in Healthcare Evolution and Transition
Introduction to Genomics
Artificial Intelligence (AI) Analysis
Software Development

Chapter 4 Impact of the COVID-19 Pandemic
Introduction
Impact of COVID-19 on the Market
Impact on MedTech
Changes in Consumption Trends for Health-Related Products

Chapter 5 Market Dynamics
Market Drivers
Investment in AI Health Sector
Increasing Strategic Moves by Market Players and Governments
Increasing Incidences of Chronic Disease
Demand for Personalized Medicine
Increasing Research and Development Budget
Restraints and Challenges
Reluctance Among Medical Practitioners to Adopt AI-Based Technologies
Ambiguous Regulatory Guidelines for Medical Software
Challenge to Maintain Data Security
Opportunities
Untapped Potential in Emerging Markets

Chapter 6 Market Breakdown by Offering
Software
Market Size and Forecast
Services
Market Size and Forecast

Chapter 7 Market Breakdown by Technology
Machine Learning
Market Size and Forecast
Computer Vision
Market Size and Forecast

Chapter 8 AI in Genomics by Application
Diagnostics
Market Size and Forecast
Drug Discovery and Development
Process of Drug Discovery
History of Drug Discovery
Classification of Techniques Used in Drug Discovery
Market Size and Forecast
Others
Market Size and Forecast

Chapter 9 Market Breakdown by Region
Global Market for AI in Genomics by Region
North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Rest of Asia-Pacific
Rest of the World

Chapter 10 Regulations and Finance
Regulatory Framework
American Diabetes Association’s Standards of Medical Care in Diabetes
ATA Guidelines for Artificial Intelligence
Indian AI Guidelines, Strategy, and Standards

Chapter 11 Patent Review

Chapter 12 Competitive Landscape
Overview
Recent Developments

Chapter 13 Company Profiles
BENEVOLENTAI
DATA4CURE INC.
DEEP GENOMICS
DNANEXUS INC.
FDNA INC.
GENOOX
INTERNATIONAL BUSINESS MACHINES CORP. (IBM)
LIFEBIT
MICROSOFT CORP.
NVIDIA
SOPHIA GENETICS



List of Figures


Summary Figure A : Global AI In Genomics Market, by Region, 2020–2027
Summary Figure B : Global Market Shares of AI in Genomics, by Region, 2021
Figure 1 : Global Funding in Health-Tech Companies
Figure 2 : Global Projections of Deaths from the Top Three Chronic Diseases, 2005–2030
Figure 3 : Increased Incidence of Cancer, 2012 and 2030
Figure 4 : Global Distribution of Deaths from Chronic Diseases, 2019
Figure 5 : Funding for Disease Research, 2014–2018
Figure 6 : Rising Trends in Healthcare Spending, by Institution, 2015–2035
Figure 7 : Global Market Shares of AI in Genomics, by Offering, 2021
Figure 8 : Global Market for AI in Genomics, by Offering, 2020–2027
Figure 9 : Global Market for Software in Software in an AI Systems, 2020–2027
Figure 10 : Global Market for AI Services, 2020–2027
Figure 11 : Global Market Shares of AI in Genomics, by Technology, 2021
Figure 12 : Global Market for AI in Genomics, by Technology, 2020–2027
Figure 13 : Global Market for Machine Learning, 2020–2027
Figure 14 : Global Market for Computer Vision, 2020–2027
Figure 15 : Global Market Shares of AI in Genomics, by Application, 2021
Figure 16 : Global Market for AI in Genomics, by Application, 2020–2027
Figure 17 : Global Market for AI in Diagnostics, 2020–2027
Figure 18 : Process of Drug Discovery
Figure 19 : Global Market for AI in Drug Discovery and Development, 2020–2027
Figure 20 : Global Market for Other Applications of AI in Genomics, 2020–2027
Figure 21 : Global Market Shares of AI in Genomics, by Region, 2021
Figure 22 : North American Market Shares of AI in Genomics, by Offering, 2021
Figure 23 : North American Market Shares of AI in Genomics, by Technology, 2021
Figure 24 : North American Market Shares of AI in Genomics, by Application, 2021
Figure 25 : North American Market Shares of AI in Genomics, by Country, 2021
Figure 26 : U.S. Market for AI in Genomics, 2020–2027
Figure 27 : Canadian Market for AI in Genomics, 2020–2027
Figure 28 : European Market Shares of AI in Genomics, by Offering, 2021
Figure 29 : European AI Genomics Market Shares, by Technology, 2021
Figure 30 : European Market Shares of AI in Genomics, by Application, 2021
Figure 31 : European Market Shares of AI in Genomics, by Country, 2021
Figure 32 : Geriatric Population in Germany, 2000-2030
Figure 33 : German Market for AI in Genomics, 2020–2027
Figure 34 : U.K. Market for AI in Genomics, 2020–2027
Figure 35 : French Market for AI in Genomics, 2020–2027
Figure 36 : Italian Market for AI in Genomics, 2020–2027
Figure 37 : Spanish Market for AI in Genomics, 2020–2027
Figure 38 : Rest of Europe Market for AI in Genomics, 2020–2027
Figure 39 : Asia-Pacific Market Shares of AI in Genomics, by Offering, 2021
Figure 40 : Asia-Pacific Market Shares of AI in Genomics, by Technology, 2021
Figure 41 : Asia-Pacific Market Shares of AI in Genomics, by Application, 2021
Figure 42 : Asia-Pacific Market Shares of AI in Genomics, by Country, 2021
Figure 43 : New Cancer Cases in China, 2020
Figure 44 : Distribution of New Cancer Cases in China, 2020
Figure 45 : Chinese Market for AI in Genomics, 2020-2027
Figure 46 : Japanese Market for AI in Genomics, 2020-2027
Figure 47 : Indian Market for AI in Genomics, 2020–2027
Figure 48 : Rest of Asia-Pacific Market for AI in Genomics, 2020–2027
Figure 49 : New Cancer Cases in Africa, 2020
Figure 50 : Rest of the World Market Shares of AI in Genomics, by Offering, 2021
Figure 51 : Rest of the World Market Shares of AI in Genomics, by Technology, 2021
Figure 52 : Rest of the World Market Shares of AI in Genomics, by Application, 2021
Figure 53 : Microsoft Corp.: Revenue Share, by Region/Country, 2021

List of Tables


Summary Table : Global Market for AI in Genomics, by Region, Through 2027
Table 1 : Cancer Statistics Across Major Asian Countries, by Cancer Site/Type, 2020
Table 2 : Global Market for AI in Genomics, by Offering, Through 2027
Table 3 : Global Market for AI in Genomics, by Technology, Through 2027
Table 4 : Global Market for AI in Genomics, by Application, Through 2027
Table 5 : History of Drug Discovery
Table 6 : Global Market for AI in Genomics, by Region, Through 2027
Table 7 : North American Market for AI in Genomics, by Offering, Through 2027
Table 8 : North American Market for AI in Genomics, by Technology, Through 2027
Table 9 : North American Market for AI in Genomics, by Application, Through 2027
Table 10 : North American Market for AI in Genomics, by Country, Through 2027
Table 11 : European Market for AI in Genomics, by Offering, Through 2027
Table 12 : European Market for AI in Genomics, by Technology, Through 2027
Table 13 : European Market for AI in Genomics, by Application, Through 2027
Table 14 : European Market for AI in Genomics, by Country, Through 2027
Table 15 : Asia-Pacific Market for AI in Genomics, by Offering, Through 2027
Table 16 : Asia-Pacific Market for AI in Genomics, by Technology, Through 2027
Table 17 : Asia-Pacific Market for AI in Genomics, by Application, Through 2027
Table 18 : Asia-Pacific Market for AI in Genomics, by Country, Through 2027
Table 19 : Number of New Cancer Cases in Japan in Both Sexes, 2020
Table 20 : Rest of the World Market for AI in Genomics, by Offering, Through 2027
Table 21 : Rest of the World Market for AI in Genomics, by Technology, Through 2027
Table 22 : Rest of the World Market for AI in Genomics, by Application, Through 2027
Table 23 : Regulations Pertaining AI Genomics in Select Countries
Table 24 : Analysis of Patents Related to AI in Genomics
Table 25 : Leading Market Players in the AI Genomics Market Ecosystem
Table 26 : BenevolentAI: Product Portfolio
Table 27 : Data4Cure: Product Portfolio
Table 28 : Deep Genomics: Product Portfolio
Table 29 : DNAnexus: Product Portfolio
Table 30 : FDNA Inc.: Product Portfolio
Table 31 : Genoox: Product Portfolio
Table 32 : IBM Corp.: Company Financials, 2020 and 2021
Table 33 : IBM: Product Portfolio
Table 34 : IBM Corp.: Company Strategic Developments, 2017-2019
Table 35 : Lifebit: Product Portfolio
Table 36 : Microsoft Corp.: Financials, 2019-2021
Table 37 : Microsoft Corp.: Product Portfolio
Table 38 : Microsoft Corp.: Strategies and Developments
Table 39 : Nvidia: Company Financials, 2019 and 2020
Table 40 : Nvidia: Product Portfolio
Table 41 : SOPHiA GENETICS: Product Portfolio